|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-1.15/--
|
企业价值
6.79B
|
资产负债 |
每股账面净值
-0.87
|
现金流量 |
现金流量率
--
|
损益表 |
收益
622.00K
|
每股收益
0.00
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/05 17:43 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. Geographically, the company operates in United States and Europe. Majority of the revenue is generated from Europe. |